Healthcare

Union Hospital-China bags two awards at the Healthcare Asia Awards 2018

The hospital won the Facilities Improvement Initiative of the Year and the ICT Initiative of the Year

Union Hospital-China bags two awards at the Healthcare Asia Awards 2018

The hospital won the Facilities Improvement Initiative of the Year and the ICT Initiative of the Year

Alibaba sells medical assets to Hong Kong arm for $10.6b

Alibaba Health Information Technology will control the Tmall and adult products business.

St. Luke's Medical Center - Global City, Philippines bags three awards at the Healthcare Asia Awards 2018

The hospital won Management Innovation of the Year, Service Innovation of the Year, and Employee Engagement of the Year, making it the most awarded...

2018 Healthcare Asia Forum Bangkok closes 4-city roadshow

Executives from Thailand's big hospitals and healthcare firms converged at the event.

Malaysia poised to become ASEAN healthcare hub

Amidst rising costs, the country has been aggressive in pushing for better healthcare delivery.

IHH Healthcare profits crashed 88% to $19.25m

It was hit by costs from opening Gleneagles Hong Kong Hospital and Acibadem Altunizade Hospital.

Health care plans don't work for nearly 2 in 5 employees

Employers could not be getting a good return on their investments in health.

Fullerton Healthcare Group bags three awards at the Healthcare Asia Awards 2018

The healthcare provider is recognised for Primary Care Provider of the Year, Patient Care Initiative of the Year, and Facilities Improvement...

Health Management International buys S$40m share in StarMed

It will own 62.5% stake in Singapore's first private one-stop ambulatory care centre.

Australia to shell out $96.9m for elderly care

A whopping $61.2m will be for mental health services for people in residential aged care facilities.

2018 Healthcare Asia Forum Kuala Lumpur welcomed almost 60 delegates

Executives from Malaysia's big hospitals and healthcare firms converged at the event.

Singapore's pharma sector taps into generic medicine market to curb higher expenses

Their market share of sales is forecast to rise from 31.4% in 2017 to 38.9% by 2027 at $690m.